ONCO (Onconetix) FFO


ONCO Onconetix Inc ONCO
23 GF Score
Price $0.98
! 4 Warning Signs
View Full Analysis

What is Onconetix FFO?

FFO (Funds from operations) only applies to REITs.

ONCO
23GF Score
Onconetix Inc ONCO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onconetix Business Description

Address 201 E. Fifth Street, Suite 1900, Cincinnati, OH, USA, 45202
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
23GF Score

Get the complete analysis for ONCO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price